Neuralstem Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Neuralstem Inc
TickerPALI
CIK #0001357459
CUSIP696389105
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address9700 Great Seneca Highway, Rockville, MD 20850
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Palisade Bio Inc 2024-05-10 4.0 M Exemption: 506(b) · Duration: One year or less · Commission: $309,999 · Revenue: Decline to Disclose
Seneca Biopharma Inc 2020-01-28 7.6 M Exemption: 506(b) · Duration: One year or less · Commission: $604,444 · Revenue: Decline to Disclose
Neuralstem Inc 2017-05-31 0.0 M Exemption: 506(b) · Minimum: $12,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001357459] 10-K
[0001357459] 10-Q
[0001357459] 3
[0001357459] 4
[0001357459] 5
[0001357459] 8-K
[0001357459] D
[0001357459] SC 13D
[0001357459] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Soleus Capital Master Fund LP Palisade Bio Inc [2026-05-27] 0.0
Ameriprise Financial Inc Palisade Bio Inc [2026-05-15] 0.0
Octagon Capital Advisors LP Palisade Bio Inc [2026-02-10] 0.0
Franklin Resources Inc Palisade Bio Inc [2026-01-29] 0.0
Janus Henderson Group PLC Palisade Bio Inc [2025-12-08] 0.0
Perceptive Advisors LLC Palisade Bio Inc [2025-10-09] 0.0
RA Capital Management LP Palisade Bio Inc [2025-10-09] 0.0
Deep Track Capital LP Palisade Bio Inc [2025-10-08] 0.0
Commodore Capital LP Palisade Bio Inc [2025-10-08] 0.0
Squadron Capital Management LLC Palisade Bio Inc [2025-10-08] 0.0
Point72 Asset Management LP Palisade Bio Inc [2025-10-07] 0.0
Armistice Capital LLC Palisade Bio Inc [2024-11-14] 0.99
Lind Global Fund II LP Palisade Bio Inc [2023-09-15] 7.9
L1 Capital Global Opportunities Master Fund Ltd Palisade Bio Inc [2023-09-15] 6.4
Armistice Capital LLC Palisade Bio Inc [2023-02-14] 0.99
Intracoastal Capital LLC Palisade Bio Inc [2022-08-22] 0.99
Lind Global Fund II LP Palisade Bio Inc [2022-08-18] 6.2
Altium Capital Management LP Palisade Bio Inc [2022-02-14] 9.99
YUMA Regional Medical Center Palisade Bio Inc [2021-08-30] 19.0
Altium Capital Management LP Palisade Bio Inc [2021-05-11] 9.82
Armistice Capital LLC Seneca Biopharma Inc [2020-05-29] 4.99
Renaissance Technologies LLC Seneca Biopharma Inc [2020-02-12] 6.7
Intracoastal Capital LLC Neuralstem Inc [2019-08-09] 0.99
Armistice Capital LLC Neuralstem Inc [2018-11-05] 5.7
Sabby Management LLC Neuralstem Inc [2018-10-26] 8.26
Hudson Bay Capital Management LP Neuralstem Inc [2018-02-02] 5.83
CVI Investments Inc Neuralstem Inc [2017-08-07] 8.3
Tianjin Pharmaceuticals Group Holdings Co Ltd Neuralstem Inc [2017-02-27] 19.99
Putnam Investments LLC Neuralstem Inc [2015-02-17] 6.5
JOHE Karl Neuralstem Inc [2014-03-06] 14.1
GARR Richard Neuralstem Inc [2014-03-06] 7.5
[2012-08-22] None
[2012-02-16] None
Form 3/4/5 Filer 2011 - 2026
Baltera Robert Jr
Palisade Bio Inc
Jones Mitchell Lawrence
Finley John David
Zwick Jordan Michael
Chuang Emil
Wei Binxian
Williams Donald Allen
Fischbein Margery B
Diaz Stephanie
Trenschel Robert J
Neal James R
Csimma Cristina
Gray Mary Ann
McRae Robert Curtis
Hallam Thomas
Dawson Michael John
Yuma Regional Medical Center
Mazzo David J
Carter Kenneth C
Smith Sandford D
Oldaker William Clyde
Ogilvie Scott Varde
Westreich Stanley
Daly Richard J
Lloyd Jones Jonathan Brian
GARR Richard
JOHE Karl
Sohn Catherine A
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Finley John David
Common Stock
2026-02-12 Sell 3,896 $1.75 6,818
Jones Mitchell Lawrence
Common Stock
2026-02-12 Sell 1,989 $1.75 3,481
Finley John David
Common Stock
2026-02-11 Option exercise 13,333
Jones Mitchell Lawrence
Common Stock
2026-02-11 Option exercise 8,000
Finley John David
Restricted Stock Units · derivative
2026-02-11 Option exercise 13,333 $0.00
Jones Mitchell Lawrence
Restricted Stock Units · derivative
2026-02-11 Option exercise 8,000 $0.00
Finley John David
Restricted Stock Units · derivative
2026-02-09 Grant 2,011,000 $0.00
Jones Mitchell Lawrence
Restricted Stock Units · derivative
2026-02-09 Grant 787,000 $0.00
Williams Donald Allen
Common Stock
2026-01-16 Buy 5,000 $1.67 8,350
Williams Donald Allen
Common Stock
2026-01-09 Buy 5,000 $1.88 9,400
Williams Donald Allen
Restricted Stock Units · derivative
2025-10-06 Grant 1,538,700 $0.00
Jones Mitchell Lawrence
Restricted Stock Units · derivative
2025-10-06 Grant 7,665,800 $0.00
Finley John David
Restricted Stock Units · derivative
2025-10-06 Grant 9,179,400 $0.00
Wei Binxian
Restricted Stock Units · derivative
2025-10-06 Grant 510,700 $0.00
Chuang Emil
Restricted Stock Units · derivative
2025-10-06 Grant 510,700 $0.00
Restricted Stock Units · derivative
2025-10-06 Grant 60,600 $0.00
Restricted Stock Units · derivative
2025-10-06 Grant 60,600 $0.00
Restricted Stock Units · derivative
2025-10-06 Grant 182,000 $0.00
Phantom Units · derivative
2025-09-04 Grant 18,800 $0.00
Phantom Units · derivative
2025-09-04 Grant 289,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 96 149,265,837
2025-12-31 86 135,864,648
2025-09-30 12 119,592
2025-06-30 12 84,610
2025-03-31 14 296,358
2024-12-31 11 234,982
2024-09-30 10 106,057
2024-06-30 9 65,837
2024-03-31 17 970,269
2023-12-31 17 306,071
2023-09-30 14 149,932
2023-06-30 12 134,550
Form 13F Holdings
Firm Period DFND Voting Shares
Simplify Asset Management Inc [2026-06-30] SOLE 450,543 450,543
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 0 29,228
NorthCrest Asset Manangement LLC [2026-06-30] SOLE 0 12,203
FNY Investment Advisers LLC [2026-06-30] SOLE 8,500 10
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com